Maravai Lifesciences Holdings (MRVI) Tax Provisions (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) recorded quarterly Tax Provisions of -$151000.0 in Q1 2026, down 2616.67% quarter-over-quarter from $6000.0 in Q4 2025, and down 193.21% on a YoY basis from $162000.0 in Q1 2025.
Maravai Lifesciences Holdings (MRVI) Tax Provisions (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Tax Provisions history runs 7 years deep, the most recent figure standing at -$151000.0 for Q1 2026.
- In Q1 2026, Tax Provisions fell 193.21% year-over-year to -$151000.0; the TTM figure through Mar 2026 stood at -$4.5 million (down 129.81% YoY), while the FY2025 annual figure was -$4.2 million, down 126.45% from the prior year.
- Tax Provisions was -$151000.0 for Q1 2026 at Maravai Lifesciences Holdings, down from $6000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $766.2 million in Q4 2023 to a low of -$5.5 million in Q3 2023.
- Historically, Tax Provisions has averaged $47.7 million across 5 years, with a median of $6000.0 in 2025.
- The sharpest annual moves came in 2023 and 2026: Tax Provisions soared 8970.3% in 2023, then tumbled 193.21% in 2026.
- A 5-year view of Tax Provisions shows it stood at $8.4 million in 2022, then jumped by 8970.3% to $766.2 million in 2023, then plunged by 100.0% to -$7000.0 in 2024, then soared by 185.71% to $6000.0 in 2025, then tumbled by 2616.67% to -$151000.0 in 2026.
- The last three Tax Provisions figures came in at -$151000.0 (Q1 2026), $6000.0 (Q4 2025), and -$92000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Maravai Lifesciences Holdings | 737.25 Mn | 728.85 Mn | 33.70 Mn | -151,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -151,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | -92,000.00 |
| Jun 30, 2025 | -4.29 Mn |
| Mar 31, 2025 | 162,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Sep 30, 2024 | 311,000.00 |
| Jun 30, 2024 | -2.44 Mn |
| Mar 31, 2024 | 271,000.00 |
| Dec 31, 2023 | 766.17 Mn |
| Sep 30, 2023 | -5.46 Mn |
| Jun 30, 2023 | -1.42 Mn |
| Mar 31, 2023 | -3.18 Mn |
| Dec 31, 2022 | 8.45 Mn |
| Sep 30, 2022 | 14.11 Mn |
| Jun 30, 2022 | 18.27 Mn |
| Mar 31, 2022 | 19.98 Mn |
| Dec 31, 2021 | 17.58 Mn |
| Sep 30, 2021 | 18.84 Mn |
| Jun 30, 2021 | 11.39 Mn |